期刊文献+

RNA干扰技术对肝癌细胞内源survivin基因表达的影响 被引量:16

RNA Interference-mediated Inhibition of Endogenous Survivin Expression in Hepatocarcinoma Cell
下载PDF
导出
摘要 应用RNA干扰技术(RNAi)研究针对凋亡抑制因子survivin的siRNA抑制肝癌细胞株内源survivin基因的表达.转染重组质粒pshRNA survivin至肝癌细胞株SMMC 772 1,通过免疫荧光、蛋白质印迹和半定量RT PCR检测survivin蛋白表达及mRNA转录水平的变化.结果表明:构建的三种重组质粒pshRNA survivin1/2/3均能明显抑制survivin基因的表达;应用免疫荧光检测survivin基因的表达,转染重组质粒pshRNA survivin的实验组survivin荧光强度明显低于转染载体pTZU6 +1和pshRNA GFP对照组;蛋白质印迹结果表明,重组质粒pshRNA survivin明显抑制survivin蛋白的表达,抑制率为 6 2 %~ 78%,通过半定量RT PCR检测到survivin基因mRNA转录明显减少,抑制率为5 7%~ 6 4 %.由上述结果可以得出结论:重组质粒pshRNA survivin可明显抑制SMMC 772 1细胞内源survivin的表达和mRNA的转录。 To apply the small interfering RNAs targeting survivin to inhibit expression of endogenous survivin gene in human hepatocarcinoma cell SMMC-7721, the recombinant plasmid pshRNA-survivins were transfeetted into SMMC-7721. The expression level of survivin was determined by Western blot and immunofluorescence staining the transcription of survivin gene was detected by semi-quantitative RT-PCR. The introduction of plasmids pshRNA-survivin was showed to efficiently and specifically inhibit the expression of survivin according to results of Western blot and immunofluorescence staining, with inhibitory rates at 62% similar to 78% peaking 72 h. Semi-quantitative RT-PCR showed that mRNA transcription of survivin gene was reduced by nearly 57% similar to 64%. On the contrast, the control plasmid did exhibit no inhibitory effect on the protein expression and mRNA transcription of survivin gene. The results demonstrate that the small interfering RNA targeting survivin gene shows dramastic inhibition on protein expression and RNA transcription.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2004年第9期829-833,共5页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金资助项目(3 0 3 715 99) 国家杰出青年基金资助(B类)(3 0 2 2 80 2 6)~~
关键词 RNA干扰 肝癌细胞株 SURVIVIN基因 RNA interference hepatocarcinoma cell survivin gene
  • 相关文献

参考文献9

  • 1Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma. Nat Med, 1997, 3(8): 917 -921
  • 2Grossman D, Kim P, Schechner J S, et al. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA,2001, 98 (2): 635 -640
  • 3Mesri M, Wall N R, Li J, et al. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest, 2001, 108 (7): 981 -990
  • 4Tuschl T. Expanding small RNA interference. Nat Biotechnol,2002, 20 (5): 446 - 448
  • 5Olie R A, Simoes-Wust P, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res, 2000, 60(11): 2805-2809
  • 6McManus M T, Sharp P A. Gene silencing in mammals by small interfering RNAs. Nature Rev Genet, 2002, 3 (10): 737 -747
  • 7Aoki Y, Cioca D P, Oidaira H, et al. RNA interference may be more potent than antisense RNA in human cancer cell lines. Clin Exp Pharmacol Physiol, 2003, 30 ( 1 - 2 ): 96 - 102
  • 8Song E, Lee S K, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 2003, 9 (3):347 - 351
  • 9Cioca D P, Aoki Y, Kiyosawa K. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Ther, 2003, 10 (2): 125 -133

共引文献1

同被引文献240

引证文献16

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部